Sun Pharmaceuticals Industries Ltd logo

SUNPHARMA

Sun Pharmaceuticals Industries Ltd

₹1,780

Sun Pharmaceuticals Industries Ltd Q2 FY2024-2025 Results: Summary

Revenue
₹13,645.39Cr
Net Profits
₹3,040.16Cr
Net Profit Margins
22.28%

Highlights

Revenue:

Sun Pharmaceuticals Industries Ltd’s revenue jumped 9.29% since last year same period to ₹13,645.39Cr in the Q2 2024-2025. On a quarterly growth basis, Sun Pharmaceuticals Industries Ltd has generated 3.49% jump in its revenue since last 3-months.

Net Profits:

Sun Pharmaceuticals Industries Ltd’s net profit jumped 27.98% since last year same period to ₹3,040.16Cr in the Q2 2024-2025. On a quarterly growth basis, Sun Pharmaceuticals Industries Ltd has generated 7.21% jump in its net profits since last 3-months.

Net Profit Margins:

Sun Pharmaceuticals Industries Ltd’s net profit margin jumped 17.11% since last year same period to 22.28% in the Q2 2024-2025. On a quarterly growth basis, Sun Pharmaceuticals Industries Ltd has generated 3.6% jump in its net profit margins since last 3-months.

FAQs

The revenue for Sun Pharmaceuticals Industries Ltd in the Q2 results 2024 was ₹13,645.39Cr.

The net profit for Sun Pharmaceuticals Industries Ltd in the Q2 results 2024 was ₹3,040.16Cr.

The net profit margin for Sun Pharmaceuticals Industries Ltd in the Q2 results 2024 was 22.28%.

The revenue for Sun Pharmaceuticals Industries Ltd in the Q2 results 2023 was ₹12,486.02Cr.

The net profit for Sun Pharmaceuticals Industries Ltd in the Q2 results 2023 was ₹2,375.51Cr.

The net profit margin for Sun Pharmaceuticals Industries Ltd in the Q2 results 2023 was 19.03%.